New knowledge about bone marrow transplants can help leukemia patients

Johan Jansson's research at Kalmar University in Sweden shows that cancer cells that have been exposed to chemotherapy and survived are less vulnerable to chemotherapy, and more aggressive as well.

But this research also yielded discoveries that should be able to enhance our treatment of the disease.

Johan Jansson's research shows that leukemia cells that have been exposed to chemotherapy and survived did not develop resistance against bone marrow transplants from a sibling, for example. At the same time, however, several important changes were observed in these cancer cells. On the one hand, they were less vulnerable to chemotherapy and, on the other, their growth rate increased.

Johan Jansson also identified several immunologically important genes that either increased or decreased when they had been exposed to a bone marrow transplant. Three of these genes were especially interesting in that they were involved in activating the immune defense and the killing of cancer cells. It was also shown that such a bone marrow transplant could have an inhibiting effect on the leukemia cells that also proved to be able to activate parts of the immune defense.

Finally, Johan Jansson studied whether it is possible to check the leukemia cells that remain after a bone marrow transplant. This was done by vaccinating mice with a mixture of 'dead' leukemia cells and immune cells from a donor. It was observed that the immune defense was activated to some degree, but that the mice did not live any longer as a result. On the other hand, it was seen that these mice had B cells that produced antibodies against leukemia cells. This knowledge could be further elaborated to develop and enhance the effects of a bone marrow transplant.

Thesis directors: Prof. Craig A. Mullen, University of Rochester, NY, USA; Prof. Sven Tågerud, Kalmar University, Sweden.

Deputy director: Prof. Kristina Nilsson Ekdahl, Kalmar University.

External examiner: Prof. Mikael Sigvardsson, Linköping University, Sweden

Johan Jansson can be reached at jo.jansson@gmail.com or phone: +1-585-719-5562 and through October 6 at cell phone: +46-73 3988792

Sven Tågerud can be reached at sven.tagerud@hik.se, phone: +46 (0)480-44 62 56.

Pressofficer Karolina Ekstrand; karolina.ekstrand@hik.se; +46-766476 030

Media Contact

Karolina Ekstrand idw

More Information:

http://www.vr.se

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

Superradiant atoms could push the boundaries of how precisely time can be measured

Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…

Ion thermoelectric conversion devices for near room temperature

The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…

Zap Energy achieves 37-million-degree temperatures in a compact device

New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…

Partners & Sponsors